Persistence Market Research published a report on the trichomonas rapid testing market, which considers the global industry analysis 2014 – 2018 and opportunity assessment 2019-2029, and projects thatthetrichomonas rapid testing market<\/strong>is expected to reach~ US$ 360 Mn<\/strong>by the end of2019<\/strong>in terms of value, and is forecasted toreach ~ US$ 590 Mn<\/strong>by the end of 2029.<\/p>\n Rising Prevalence of Trichomoniasis Infection<\/strong><\/p>\n In a report by World Health Organization, it is stated that the worldwide annual incidence rate of trichomoniasis is over 170 million cases. The prevalence of trichomonas infection is highest among other STDs such as Chlamydia trachomatis and Neisseria gonorrhoeae.<\/p>\n Get Sample Copy of Report @https:\/\/www.persistencemarketresearch.com\/samples\/19603<\/a><\/strong><\/p>\n Company Profile<\/strong><\/p>\n According to the Centers for Disease Control and Prevention (CDC), at any given time, 3.7 million people are infected in Americas only, and one million new cases are estimated each year. Many studies evaluate that the prevalence of trichomonas infection affects more than 11% of women aged between 40 to 49 years.<\/p>\n Therefore, the rise in patient pool suffering from trichomonas infection throughout the globe will upsurge the growth of the trichomonas rapid testing market.<\/p>\n Get To Know Methodology of Report @https:\/\/www.persistencemarketresearch.com\/methodology\/19603<\/a><\/strong><\/p>\n Availability of Broad Options for Diagnosis Anticipated to Drive the Market Growth<\/strong><\/p>\n Innovation and advancements in the diagnostics industry, especially in the diagnosis of sexually transmitted infections like trichomoniasis that are hard to detect, have resulted in the availability of wide range of products in the market for trichomonas rapid testing.<\/p>\n In the current scenario, the options that are available in the market for trichomonas rapid testing usually come in the form of strips, swabs, cassettes, and assay kits. Evolution and improvements in trichomonas rapid testing avenues have also led to the development of point-of-care and self-test methods.<\/p>\n As an added value to the time and money spent by hospitals, clinics, and other end users, these trichomonas rapid testing kits have shown sensitivity and specificity rates that coincide with that of gold-standard testing methods. Thus, advancements in trichomonas rapid testing kits are likely to boost the revenue generation of the trichomonas rapid testing market.<\/p>\n Access Full Report @https:\/\/www.persistencemarketresearch.com\/checkout\/19603<\/a><\/strong><\/p>\n High Risk of HIV and Other Serious Infections Elevating Demand<\/strong><\/p>\n Recent developments in research over trichomoniasis with the availability of trichomonas rapid testing kits have determined that once an over-looked infection, trichomoniasis now has been associated with many serious health threats, especially in women.<\/p>\n Many studies done over a number of groups of high-risk population have shown strong evidence that trichomonas vaginalis increases both transmission and acquisition of HIV, the causative agent of AIDS, among women. Additionally, in affected pregnant women, trichomoniasis infection has been noticed to be the cause of premature delivery and low birth weight of babies.<\/p>\n According to CDC, the reoccurrence rate of the infection in women can be as high as 17 percent even after three months of treatment. Use of trichomonas rapid testing kits is recommended by doctors time-to-time to detect the infection. All these factors are likely to elevate the market growth for trichomonas rapid testing even further.<\/p>\n<\/div>\n Explore Extensive Coverage of PMR`sLife Sciences & Transformational Health<\/a>Landscape<\/strong><\/p>\n Molecular Diagnostics Market –<\/strong><\/p>\n Molecular Diagnostics Market<\/a>Segmentation by Key Players – Novartis AG, Roche Diagnostics, QIAGEN, Siemens Healthcare, Abbott Laboratories, Inc., Gen-Probe, Inc. (Hologic Inc.), Cepheid, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, Myriad Genetics, Inc., and bioMerieux.<\/p>\n Next-Generation Sequencing Market –<\/strong><\/p>\n Next Generation Sequencing Market<\/a>Segmented by(By Application – Whole-genome Sequencing ,Exome Sequencing,Targeted Resequencing,De Novo Sequencing,RNA Sequencing,ChIP Sequencing,Methyl Sequencing,Others);By Technology- Targeted Sequencing & Resequencing,Whole Genome Sequencing,Whole Exome Sequencing.<\/p>\n Ophthalmology devises Market –<\/strong><\/p>\n Ophthalmology devises Market<\/a>Segmentation by Key Players – Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., Essilor International S.A, Ziemer Ophthalmic Systems AG and Topcon Corporation.<\/p>\n Intravenous Iron Drugs Market –<\/strong><\/p>\n Intravenous (IV) Iron Drugs Market<\/a>Segmentation by Key Players- Actavis, Inc., AMAG Pharmaceuticals, Inc., Galenica Ltd., Fresenius Medical Care AG & Co. KGaA, Vifor Pharma Ltd., American Regent, Inc., Luitpold Pharmaceuticals, Inc., Pharmacosmos A\/S, Rockwell Medical Technologies, Inc., and Sanofi.<\/p>\n Syndromes Progressive Ataxia Weakness Disorders Market –<\/strong><\/p>\n Treatments forSyndromes of Progressive Ataxia and Weakness Disorders Market<\/a>Segmentation by Key Players- Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.<\/p>\n About us:<\/strong><\/p>\n Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.<\/p>\n To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.<\/p>\n Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.<\/p>\n Contact us:<\/strong><\/p>\n 305 Broadway, 7th Floor <\/p>\n Tags: Trichomonas Rapid Testing Market Demand<\/a>, Trichomonas Rapid Testing Market Development<\/a>, Trichomonas Rapid Testing Market Forecast<\/a>, Trichomonas Rapid Testing Market Growth<\/a>, Trichomonas Rapid Testing Market Revenue Share<\/a>, Trichomonas Rapid Testing Market Size<\/a>, Trichomonas Rapid Testing Market Supply<\/a>, Trichomonas Rapid Testing Market Trends<\/a>, Trichomonas Rapid Testing Market Analysis<\/a><\/p>\n 305 Broadway, 7th Floor Tags:<\/b> 305 Broadway, 7th Floor![\"trichomonas](\"https:\/\/www.persistencemarketresearch.com\/images\/trichomonas-rapid-testing-market.jpg\" "\\"Trichomonas")
<\/p>\n\n
\nNew York City, NY 10007
\nUnited States
\nPh.no. +1-646-568-7751
\nE-mail id-sales@persistencemarketresearch.com<\/a>
\nWebsite:https:\/\/www.persistencemarketresearch.com<\/a><\/p>\n<\/div>\n
Contact Information:<\/b><\/p>\n
New York City, NY 10007
United States
Ph.no.<\/strong> +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com<\/a><\/strong>
Website: https:\/\/www.persistencemarketresearch.com<\/a><\/strong><\/p>\n
<\/a>, Extended Distribution<\/a>, Research Newswire<\/a>, English<\/a><\/p>\n<\/div>\n
Contact Information:<\/h3>\n
New York City, NY 10007
United States
Ph.no.<\/strong> +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com<\/a><\/strong>
Website: https:\/\/www.persistencemarketresearch.com<\/a><\/strong><\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/05\/4027-1588609583.png\")
Persistence Market Research published a report on the trichomonas rapid testing market, which considers the global industry analysis 2014 – 2018 and opportunity assessment 2019-2029, and projects that the trichomonas rapid testing market is expected to reach ~ US$ 360 Mn by the end of 2019 in terms of value, and is forecasted to reach ~ US$ 590 Mn by the end of 2029. … Continue reading Trichomonas Rapid Testing Market Expected To Be Valued ~ US$ 590 Mn By 2019 to 2029<\/span><\/a> Continue Reading
<\/p>\n